Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Products>This Product

Personal Genome Machine (PGM™) Sequencer

Product Image
Product Description

The Personal Genome Machine (PGM™) Sequencer is a benchtop PostLight™ semiconductor-based platform that performs a sequencing run in approximately two hours. With a small benchtop footprint and a weight of 65 lbs (~30kg), low cost sequencing reagents, and simple touchscreen user interface, the Personal Genome Machine (PGM™) Sequencer brings next generation sequencing to every lab. The PGM™ Sequencer requires a Torrent Server for operation. The PGM™ includes a one year warranty on parts, labor, and travel for service personnel. A field service installation plan for the Personal Genome Machine System maximizes your productivity with installation of the Personal Genome Machine™ System by one of our certified field service engineers.

Features of the Personal Genome Machine™ Sequencing Platform Include:

• Scalable (1000x) semiconductor technology
• Natural biochemistry using inexpensive reagents
• Compatibility with all current library preparation methods
• Sequencing run times of about 2 hours
• A straightforward touchscreen user interface

The Personal Genome Machine™ advances Next-Generation sequencing to PostLight™ sequencing—the translation of chemical sequence information directly into digital form. PostLight™ technology means genetic sequencing is leveraged by the extreme scalability of semiconductor technology. Moore’s law is applied to genetic analysis.

Affordable Sequencing For Nearly Every Lab

Previous sequencing technologies have relied upon optical systems as bridges between the chemical and digital forms of sequence information. These systems have added tremendous costs to sequencers, relegating them to only the largest laboratories. By eliminating the need for the optical system, the Personal Genome Machine™ provides sequencing that is simpler, faster, more cost effective, and more scalable than any other technology available. With a small benchtop footprint and weight of 65 lbs (~30kg), low cost sequencing reagents, and a simple.

Product Personal Genome Machine (PGM™) Sequencer
Company Life Technologies
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Life Technologies
3175 Staley Road Grand Island, NY 14072 USA

Tel: +1.800.955.6288
Fax: +1.800.331.2286

Scientific News
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
CRISPR-Cas9 Gene Editing: Check Three Times, Cut Once
Two new studies from UC Berkeley should give scientists who use CRISPR-Cas9 for genome engineering greater confidence that they won’t inadvertently edit the wrong DNA.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.


Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos